Calidi Biotherapeutics (CLDI) Institutional Ownership → CEO of Biggest AI Chipmaker Just Dropped a Bombshell… (From Banyan Hill Publishing) (Ad) Free CLDI Stock Alerts $0.23 -0.01 (-5.99%) (As of 05/17/2024 08:53 PM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartEarningsHeadlinesOwnershipShort InterestStock AnalysisAnalyst ForecastsChartEarningsHeadlinesOwnershipShort Interest Institutional Ownership Changes (13F Filings) for Calidi Biotherapeutics (NYSEAMERICAN:CLDI)CurrentInstitutional OwnershipPercentage12.53%Number ofInstitutional Buyers(last 12 months)4Number ofInstitutional Sellers(last 12 months)0 Get CLDI Insider Trade Alerts Want to know when executives and insiders are buying or selling Calidi Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Ad Weiss Ratings[URGENT] DO NOT Touch These AI Stocks!Artificial intelligence stocks are carrying the market. One of them, Nvidia, recently became the seventh company ever to hit a $1 trillion market cap. But is this AI rally over?Click here for our #1 AI Stock for 2024 and Beyond Calidi Biotherapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/16/2024 Apollo Management Holdings L.P.125,000$71K0.0%N/A0.352% 5/15/2024 Magnetar Financial LLC63,132$36K0.0%N/A0.178% 5/14/2024 Evermay Wealth Management LLC63,416$36K0.0%N/A0.178% 4/23/2024 Spectrum Asset Management Inc. NB CA 166,494$94K0.0%N/A0.468% (Data available from 1/1/2016 forward) CLDI Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CLDI shares? During the previous two years, the following institutional investors and hedge funds held shares of Calidi Biotherapeutics shares: Spectrum Asset Management Inc. NB CA ($94K), Apollo Management Holdings L.P. ($71K), and Magnetar Financial LLC ($36K), Evermay Wealth Management LLC ($36K).Learn more on CLDI's institutional investors. What percentage of Calidi Biotherapeutics stock is owned by institutional investors? 12.53% of Calidi Biotherapeutics stock is owned by institutional investors. Learn more on CLDI's institutional investor holdings. Which institutional investors have been buying Calidi Biotherapeutics stock? The following institutional investors have purchased Calidi Biotherapeutics stock in the last 24 months: Spectrum Asset Management Inc. NB CA ($166.49K), Apollo Management Holdings L.P. ($125K), Evermay Wealth Management LLC ($63.42K), and Magnetar Financial LLC ($63.13K). How much institutional buying is happening at Calidi Biotherapeutics? Institutional investors have bought a total of 418,042 shares in the last 24 months. This purchase volume represents approximately $0.00 in transactions. Related Companies: Inhibikase Therapeutics Major Shareholders Genetic Technologies Major Shareholders BioCardia Major Shareholders Creative Medical Technology Major Shareholders TC Biopharm Major Shareholders Finch Therapeutics Group Major Shareholders Coeptis Therapeutics Major Shareholders Eloxx Pharmaceuticals Major Shareholders Tevogen Bio Major Shareholders Senti Biosciences Major Shareholders This page (NYSEAMERICAN:CLDI) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersBill Gates is all about this tiny $2 stockTimothy SykesCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingDems have chosen Biden replacement?Paradigm PressMan who spotted Apple at $1.49 says: “Buy These 6 AI Stocks.”InvestorPlaceForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the Markets[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsBuy this small stock before coming AI Tidal WaveChaikin AnalyticsShocking $16T Elon Musk Crypto LeakCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Calidi Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
